Dillard, C., Singhal, R., Pasvolsky, O., Nze, C., Feng, L., Hunzeker, Z., Ye, J. C., Thomas, S., Becnel, M., Gaballa, M., Weber, D., Richards, T., Diaz, F., Ahmed, S., Hawkins, M., Johnson, N., Ow, K., Adkins, S., Lewis, J., Kroll, M., Orlowski, R., Hildebrandt, M., Patel, K. (2025). Treatment history, not race or duffy-null status, predicts outcomes with teclistamab in Relapsed/Refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-4575